Into production and commercialisation: Medi-OS medically certified operating system
投入生产和商业化:Medi-OS 医学认证操作系统
基本信息
- 批准号:830185
- 负责人:
- 金额:$ 12.74万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Innovation Loans
- 财政年份:2021
- 资助国家:英国
- 起止时间:2021 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The pandemic has challenged healthcare providers around the world as they deliver care for patients with non-COVID-19 cardiovascular and respiratory conditions. By necessity, remote consultations have rapidly replaced many in-person clinics and assessments. In parallel, patients have also quickly adopted the convenience of medical monitoring in the home as they have become skilled, activated, and empowered by self-care.While the pandemic has driven this rapid adoption of innovation, it has also had a significant negative impact on patients recovering from heart procedures and from hospital stays due to non-coronavirus-related respiratory episodes.Many in-person cardiac rehabilitation programmes and their equivalent for patients with lung disease (pulmonary rehabilitation) have closed and these services may not re-open for a considerable time. For example, the waiting times for a pulmonary rehabilitation programme after leaving hospital in some areas is now over 12 months.The progression of a patient along their care pathway begins before they are discharged from hospital in a process which we prefer to call "recovery" rather than "rehabilitation." A chain of healthcare professionals work with patients at distinct stages of recovery and, as long as no part of this pathway is overwhelmed, it is seamless. When the programme fails because waiting lists grow too long, or patients disengage, the chances of the patient being re-admitted to hospital increase significantly, sometimes resulting in cycles of repeated hospitalisation via the emergency department. This is not a good outcome for the patient, for the over-stretched NHS or for the taxpayer.Aseptika Ltd has developed digital tools for use by the patient during their recovery, delivering education to empower the management of their condition. Progress is monitored remotely by their clinical team.In clinical trials of our protocol called Active+me REMOTE, patient engagement in self-management can be assessed through their Patient Activation Measurement (PAM) score. This score improves substantially as a result, predicting a 20% decrease in the risk of further hospitalisation. Active+me REMOTE combines our connected medical monitors, apps, informatics, education, behavioural change, motivation to adhere to medication schedules and advice delivered remotely by their medical team, family and care-givers.In this project we bring all of this together at the patient's wrist in BuddyWOTCH (Walking, Oxygen, Temperature, Chronical, Heart & breathing rate) as a medically-certified wearable. BuddyWOTCH is always connected through the mobile and Wi-Fi networks. Vitally, and unlike consumer products, BuddyWOTCH will be certified as a medical device suitable for use as a "life-critical" medical monitor in hospitals and after the patient returns home, generating trusted information for the patient, their family and their doctors.
这场大流行给世界各地的医疗保健提供者带来了挑战,因为他们为非covid -19心血管和呼吸系统疾病患者提供护理。由于需要,远程咨询已经迅速取代了许多面对面的诊所和评估。与此同时,患者也迅速接受了家庭医疗监测的便利,因为他们已经变得熟练、活跃,并通过自我护理获得了能力。虽然大流行推动了这种对创新的快速采用,但它也对心脏手术后康复的患者和因非冠状病毒相关呼吸道疾病住院的患者产生了重大负面影响。许多面对面的心脏康复方案及其对肺病患者的等效方案(肺部康复)已经关闭,这些服务可能在相当长的一段时间内不会重新开放。例如,在一些地区,出院后等待肺部康复方案的时间现在超过12个月。在病人出院之前,他们的护理过程就开始了,这个过程我们更愿意称之为“恢复”而不是“康复”。一连串的医疗保健专业人员在不同的康复阶段与患者一起工作,只要这条道路的任何部分都没有超载,它就是无缝的。当该方案因等待名单太长或患者脱离而失败时,患者再次住院的机会大大增加,有时会导致通过急诊科反复住院的循环。这对病人、超负荷运转的NHS和纳税人来说都不是一个好结果。Aseptika有限公司开发了数字工具,供患者在康复期间使用,提供教育,以增强他们的病情管理能力。他们的临床团队远程监控病情进展。在我们的“Active+me REMOTE”方案的临床试验中,患者对自我管理的参与程度可以通过患者激活测量(PAM)评分来评估。结果,该评分显著提高,预测进一步住院的风险降低20%。Active+me REMOTE结合了我们的联网医疗监视器、应用程序、信息学、教育、行为改变、遵守药物时间表的动机,以及由医疗团队、家人和护理人员远程提供的建议。在这个项目中,我们把所有这些都放在buddywatch患者的手腕上(步行,氧气,温度,慢性,心脏和呼吸率),作为一种医学认证的可穿戴设备。buddywatch始终通过移动和Wi-Fi网络连接。最重要的是,buddywatch将被认证为一种医疗设备,适合在医院和病人回家后作为“生命攸关”的医疗监护仪使用,为病人、他们的家人和医生提供可靠的信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('', 18)}}的其他基金
An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
- 批准号:
2901954 - 财政年份:2028
- 资助金额:
$ 12.74万 - 项目类别:
Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
- 批准号:
2896097 - 财政年份:2027
- 资助金额:
$ 12.74万 - 项目类别:
Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
- 批准号:
2780268 - 财政年份:2027
- 资助金额:
$ 12.74万 - 项目类别:
Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
- 批准号:
2908918 - 财政年份:2027
- 资助金额:
$ 12.74万 - 项目类别:
Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
- 批准号:
2908693 - 财政年份:2027
- 资助金额:
$ 12.74万 - 项目类别:
Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
- 批准号:
2908917 - 财政年份:2027
- 资助金额:
$ 12.74万 - 项目类别:
Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
- 批准号:
2879438 - 财政年份:2027
- 资助金额:
$ 12.74万 - 项目类别:
Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
- 批准号:
2890513 - 财政年份:2027
- 资助金额:
$ 12.74万 - 项目类别:
Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
- 批准号:
2879865 - 财政年份:2027
- 资助金额:
$ 12.74万 - 项目类别:
Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
- 批准号:
2876993 - 财政年份:2027
- 资助金额:
$ 12.74万 - 项目类别:
Studentship
相似国自然基金
交货期敏感的单件模式产品供应链的协调优化
- 批准号:70871060
- 批准年份:2008
- 资助金额:24.0 万元
- 项目类别:面上项目
供应链中生产和配送联合排序和调度的模型、算法及应用
- 批准号:70372058
- 批准年份:2003
- 资助金额:14.0 万元
- 项目类别:面上项目
相似海外基金
An engineering biology approach for sustainable production of omega 3 and pigments from microalgae
一种利用微藻可持续生产 omega 3 和色素的工程生物学方法
- 批准号:
10107393 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Launchpad
Reducing the cost of fuel cell components and pilot production of bipolar plate coatings
降低燃料电池组件成本并试产双极板涂料
- 批准号:
10088165 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Collaborative R&D
Sustaining chicken-meat production with alternative protein sources
利用替代蛋白质来源维持鸡肉生产
- 批准号:
LP220100292 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Linkage Projects
Revolutionising Electrolysers for Low-Cost Green Hydrogen Production
革新电解槽以实现低成本绿色制氢
- 批准号:
IM240100216 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Mid-Career Industry Fellowships
Understanding the experiences of UK-based peer/community-based researchers navigating co-production within academically-led health research.
了解英国同行/社区研究人员在学术主导的健康研究中进行联合生产的经验。
- 批准号:
2902365 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Studentship
New low-cost graphene production to revolutionise engineering applications
新型低成本石墨烯生产将彻底改变工程应用
- 批准号:
2911021 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Studentship
Optimal cell factories for membrane protein production
用于膜蛋白生产的最佳细胞工厂
- 批准号:
BB/Y007603/1 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Research Grant
Sustainable Style for Clean Growth: Innovating Textile Production through Engineering Biology
清洁增长的可持续方式:通过工程生物学创新纺织品生产
- 批准号:
BB/Y007735/1 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Research Grant
CAS: Optimization of CO2 to Methanol Production through Rapid Nanoparticle Synthesis Utilizing MOF Thin Films and Mechanistic Studies.
CAS:利用 MOF 薄膜和机理研究,通过快速纳米粒子合成优化 CO2 生产甲醇。
- 批准号:
2349338 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Continuing Grant
Bridging Economic Demands with Social Responsibility: A Deep Dive into SMFDI's Production-Driven CSR Initiatives
连接经济需求与社会责任:深入探讨 SMFDI 的生产驱动型企业社会责任计划
- 批准号:
24K20993 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists